Source: Health Products Regulatory Authority (IE) Revision Year: 2015 Publisher: Phoenix Labs, Suite 12, Bunkilla Plaza, Bracetown Business Park, Clonee, Co. Meath
For the treatment of inflammatory disorders of the musculo-skeletal system.
Etoflam 5% w/w gel is applied topically. A 5-10cm strip of gel (according to the area affected) should be rubbed in gently. This may be repeated up to 4 times daily.
Clinical studies in patients with impaired renal function or undergoing anti-coagulant therapy have not indicated a need to change the recommended dosage in these patients.
The use of Etoflam 5% w/w gel is not recommended in children or infants.
It is recommended that treatment should be reviewed after 14 days. Treatment should not extend beyond 6 weeks. In symptomatic treatment of osteoarthritis, therapy should be reviewed after 4 weeks.
In view of the topical route of administration overdosage is not considered a practical possibility.
5 years.
Do not store above 25°C.
Collapsible aluminium tube with an internal coating with polyethylene screw cap. Tubes contain either 20g or 100g of gel product.
Not all pack sizes may be marketed.
No special requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
